This work used its strategy, termed neural iterative selection–expansion (NISE), to design proteins that, using different folds, specifically bind to two chemically distinct small-molecule drugs, exatecan and apixaban, with success rates of 100%, respectively.
Benjamin Fry, Kaia Slaw, Nicholas F. Polizzi· Nature· 7 citations· ⚡1